Figure 3.
DFS and OS for the NRI of breast cancer patients in different molecular subtypes. (A) DFS and OS for the NRI of breast cancer patients in different molecular subtypes in all patients; (B) DFS and OS for the NRI of breast cancer patients in different molecular subtypes in NACT group; (C) DFS and OS for the NRI of breast cancer patients in different molecular subtypes in non-NACT group.